U.S. Investing

Cannabis Corner: Reefer REIT Rocks the Market

It’s easy to criticize the bad match between most cannabis stocks and the street-level economic potential. Deregulation is creating a multi-billion-dollar industry. The stocks need a lot of work.

But dig beyond the Big Cannabis cultivators flooding the world with raw plant product and there are plenty of hot spots for investors. Innovative Industrial Properties Inc. (NYSE:IIPR) is one of the brightest.

The business model here is a little different. IIPR doesn’t grow anything. Instead, the company owns 2.8 million square feet of greenhouse space that it leases to medical marijuana cultivators.

All the slots are full and generating rent, which IIPR then passes back to shareholders. That’s right, IIPR is a Real Estate Investment Trust or REIT. This is a cannabis dividend play.

The yield isn’t huge right now at 3.8 percent, but that’s where IIPR gets interesting. Demand for greenhouse space is exploding, giving management a lot of leeway to raise rent and ultimately enrich the dividend year by year.

Two years ago, IIPR paid $0.15 per share quarterly. Here we are now at $0.78, a full 420 percent beyond that minimal starting income stream.

And the sky is the limit. We just got quarterly numbers that blew Wall Street’s most aggressive targets away: revenue practically tripled over the past year. Even management called the growth rate “tremendous.”

Part of that cash lays the groundwork for additional expansion. Since July, the property portfolio has doubled in size, so I expect at least 150 percent dividend expansion over the next few years as those greenhouses fill up with tenants.

Commodity math is our friend here. Growth space is an absolute necessity for any licensed cultivator. While anyone can build a greenhouse, funding restrictions make it tricky for start-up growers to write their own checks.

For many, renting is the only option and IIPR is the only game in town. Admittedly, management has financed its expansion by selling stock, but even after diluting existing shareholders there’s still plenty of cash to go around.

Investors who sold that story over the summer now need to come running back. After all, the float is still extremely narrow.

With under 10 million IIPR shares on the market six months ago, we now live in a world where every $1 of profit needs to stretch 14 percent farther to keep all the year-over-year comparisons the same. That’s no problem when cash flow coming in triples.

Admittedly, I’m biased. Since I added IIPR to my Turbo Trader Marijuana Millionaire Portfolio, it’s beaten the big cultivators by 13 percentage points.

We’re booking dividends quarter to quarter. And with the stock up 13 percent this week, I’m looking for a big long-term payout here soon.

Hilary Kramer

Hilary Kramer is an investment analyst and portfolio manager with 30 years of experience on Wall Street. The Financial Times describes Ms. Kramer as “A one-woman financial investment powerhouse” and The Economist distinguishes her as “one of the best-known investors in America”. Ms. Kramer is often quoted in publications such as the Wall Street JournalNew York Post, Bloomberg, and Reuters. She is a frequent guest commentator on CNBC, CBS, Fox News and Bloomberg, providing investment insight and economic analysis. Ms. Kramer was an analyst and investment banker at Morgan Stanley and Lehman Brothers.  Ms. Kramer founded and ran a long-short hedge fund and has been chief investment officer overseeing debt and equity portfolios. Since 2010, Ms. Kramer’s financial publications have provided stock analysis and investment advice to her subscribers.  Her products include GameChangers, Value Authority, High Octane Trader, Triple-Digit Trader, 2-Day Trader, IPO Edge and Inner Circle. Ms. Kramer, a Certified Fraud Examiner, has also testified as an expert in investment suitability, risk management, compliance, executive compensation, and corporate governance. Ms. Kramer received her MBA from the Wharton School at the University of Pennsylvania and her BA with honors from Wellesley College. Ms. Kramer has provided testimony regarding investment policy to the U.S. Senate and is a frequent speaker on the markets, portfolio management and securities fraud and compliance. Ms. Kramer is also the author of “Ahead of the Curve” (Simon & Schuster 2007) and “The Little Book of Big Profits from Small Stocks” (Wiley 2012).

Recent Posts

The Difference Between SPX and SPY – Options Trading

When looking to invest in the S&P 500, SPX and SPY options are similar assets…

3 days ago

Index Options – Explained and Simplified

An index option is a contract that gives the buyer the right, but not the…

3 days ago

The Most Hated Adage on Wall Street

“There’s more wisdom in your book than four years of college education!” -- Subscriber Back…

3 days ago

ETF Talk: Being Prepared for Anything with an Insurance ETF

There is a famous saying that has been floating around the internet regarding the “Five…

4 days ago

May Day, Reimagined

Today is May 1, a day that’s also known as “May Day” in many countries…

4 days ago

10 Reasons to Day-Trade with Mentors in a Virtual Room

Ten reasons to day-trade with mentors in a virtual room highlight why now is a…

5 days ago